Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim JH, Drame M, Puthanakit T, Chiu NC, et al. Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6-35 Months of Age: Results From a Phase 2, Randomized, Observer-blind, Multicenter, Dose-ranging Study. Pediatr Infect Dis J 2021 Jul 19. pii: 00006454-900000000-95743.
PMID: 34285165

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016